BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31851435)

  • 1. Peptidic Monodisperse PEG "Comb" as Multifunctional "Add-On" Module for Imaging-Traceable and Thermo-Responsive Theranostics.
    Zhu J; Zhang H; Chen K; Li Y; Yang Z; Chen S; Zheng X; Zhou X; Jiang ZX
    Adv Healthc Mater; 2020 Feb; 9(3):e1901331. PubMed ID: 31851435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidic Monodisperse PEG "combs" with Fine-Tunable LCST and Multiple Imaging Modalities.
    Zhu J; Xiao Y; Zhang H; Li Y; Yuan Y; Yang Z; Chen S; Zheng X; Zhou X; Jiang ZX
    Biomacromolecules; 2019 Mar; 20(3):1281-1287. PubMed ID: 30668906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy.
    Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X
    Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IONP-doped nanoparticles for highly effective NIR-controlled drug release and combination tumor therapy.
    Fu X; Wang X; Zhou S; Zhang Y
    Int J Nanomedicine; 2017; 12():3751-3766. PubMed ID: 28553112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
    Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
    Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
    Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Magnetic Drug Delivery System with "OFF-ON" State via Specific Molecular Recognition and Conformational Changes for Precise Tumor Therapy.
    Liu J; Liu W; Zhang K; Shi J; Zhang Z
    Adv Healthc Mater; 2020 Feb; 9(3):e1901316. PubMed ID: 31858730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake and release profiles of PEGylated liposomal doxorubicin nanoparticles: A comprehensive picture based on separate determination of encapsulated and total drug concentrations in tissues of tumor-bearing mice.
    Wang H; Zheng M; Gao J; Wang J; Zhang Q; Fawcett JP; He Y; Gu J
    Talanta; 2020 Feb; 208():120358. PubMed ID: 31816795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
    J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface-Modified Nanoerythrocyte Loading DOX for Targeted Liver Cancer Chemotherapy.
    Wang Y; Chen X; He D; Zhou Y; Qin L
    Mol Pharm; 2018 Dec; 15(12):5728-5740. PubMed ID: 30359027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation of Thermo-responsive Gel in pH-sensitive Polymersomes as Dual-Responsive Smart carriers for Controlled Release of Doxorubicin.
    Oroojalian F; Babaei M; Taghdisi SM; Abnous K; Ramezani M; Alibolandi M
    J Control Release; 2018 Oct; 288():45-61. PubMed ID: 30171978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
    Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z
    J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy.
    Zou Y; Fang Y; Meng H; Meng F; Deng C; Zhang J; Zhong Z
    J Control Release; 2016 Dec; 244(Pt B):326-335. PubMed ID: 27245309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced doxorubicin delivery to hepatocellular carcinoma cells via CD147 antibody-conjugated immunoliposomes.
    Wang J; Wu Z; Pan G; Ni J; Xie F; Jiang B; Wei L; Gao J; Zhou W
    Nanomedicine; 2018 Aug; 14(6):1949-1961. PubMed ID: 29045824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.
    Zhang Q; Chen X; Shi H; Dong G; Zhou M; Wang T; Xin H
    Colloids Surf B Biointerfaces; 2017 Dec; 160():527-534. PubMed ID: 29024917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo study of doxorubicin-loaded cell-penetrating peptide-modified pH-sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB/c nude mice bearing human breast tumors.
    Ding Y; Cui W; Sun D; Wang GL; Hei Y; Meng S; Chen JH; Xie Y; Wang ZQ
    Drug Des Devel Ther; 2017; 11():3105-3117. PubMed ID: 29123382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-Sensitive nanoparticles as smart carriers for selective intracellular drug delivery to tumor.
    Li XX; Chen J; Shen JM; Zhuang R; Zhang SQ; Zhu ZY; Ma JB
    Int J Pharm; 2018 Jul; 545(1-2):274-285. PubMed ID: 29733971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.